OmniAb, Inc.

NASDAQ:OABI

Biotechnology

Healthcare
$5.08 +7.88%

+$0.16 today

Market cap
$740.97M
Beta
1.15
P/E (TTM)
-5.2
EPS (TTM)
-$0.42
52W Low $1.30High $2.79

Volume 1.22M

Average 0.67M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$36.45M

FY 2025 · Annual

Investing Cash Flow

$6.47M

FY 2025 · Annual

-82.9% YoY

Financing Cash Flow

$27.91M

FY 2025 · Annual

+114.4% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(27.04M)(22.33M)(50.62M)(62.03M)(64.78M)
Depreciation & Amortization16.25M18.25M19.5M23.58M21.75M
Deferred Income Tax(7.33M)(6.42M)(12.54M)(9.04M)(1.53M)
Stock-Based Compensation15.07M18.32M24.82M21.5M15.82M
Change in Working Capital(2.63M)(10.83M)24.87M(10.17M)(4.95M)
Accounts Receivables6.02M(12.74M)26.9M(625K)189K
Inventory(1.51M)0000
Accounts Payables1.51M15.07M920K(2.41M)(231K)
Other Working Capital(8.65M)(13.16M)(2.95M)(7.14M)(4.91M)
Other Non-Cash Items9K(572K)(3.68M)(3.5M)(4.3M)
Operating Cash Flow(5.67M)(3.59M)2.35M(39.66M)(36.46M)
Capital Expenditures(4.07M)(17.17M)(1.64M)(1.88M)(565K)
Acquisitions (Net)00000
Purchases of Investments0(54.78M)(112.62M)(40.29M)(46.86M)
Sales of Investments1.27M70K100.32M80.45M50.89M
Other Investing Activities(1.22M)(1.44M)(4.44M)(400K)3M
Investing Cash Flow(4.03M)(73.31M)(18.38M)37.88M6.47M
Debt Repayment00000
Common Stock Issued096.24M011.37M28.36M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities9.7M14.5M(892K)1.65M(450K)
Financing Cash Flow9.7M110.74M(892K)13.02M27.91M
Effect of Forex Changes00000
Net Change in Cash033.84M(16.92M)11.24M(2.07M)
Free Cash Flow(9.74M)(20.76M)703K(41.54M)(37.02M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$64.8M
+ D&A$21.8M
+ Stock-Based Comp$15.8M
- Deferred Tax-$1.5M
- Working Capital-$5.0M
- Other Non-Cash-$4.3M
= Operating Cash Flow-$36.5M
- Capex-$565.0K
= Free Cash Flow-$37.0M

Analysis

FY2025 free cash flow is -$37.0M. FCF conversion is 57.1% of net income. Operating cash flow was -$36.5M, with capex of -$565.0K. The largest bridge item is D&A at $21.8M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 2, 2026
8-KCurrent reportOct 30, 2026
10-QQuarterly reportOct 30, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
10-QQuarterly reportAug 6, 2026

Does OABI generate free cash flow?

OmniAb, Inc. (OABI) generated -$37.02M of free cash flow in fiscal 2025.

How much operating cash flow does OABI produce?

Operating cash flow was -$36.45M, before capital expenditures of $565,000.00.